Items where authors include "Barrans, S.L."

Article

Davies, J.R., Hilton, L.K. orcid.org/0000-0002-6413-6586, Jiang, A. et al. (13 more authors) (2023) Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL. Blood Advances. ISSN 2473-9529

Alaggio, R. orcid.org/0000-0003-3915-3816, Amador, C. orcid.org/0000-0003-0352-5526, Anagnostopoulos, I. orcid.org/0000-0002-5043-6043 et al. (307 more authors) (2023) Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748. Leukemia, 37 (9). pp. 1944-1951. ISSN 0887-6924

Barrans, S.L., Fenton, J.A.L., Banham, A. et al. (2 more authors) (2004) Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood, 104 (9). pp. 2933-2935. ISSN 0006-4971

Barrans, S.L., Evans, P.A.S., O’Connor, S.J.M. et al. (5 more authors) (2003) The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome. Clinical Cancer Research, 9 (6). pp. 2133-2139. ISSN 1078-0432

Barrans, S.L., Carter, I., Owen, R.G. et al. (5 more authors) (2002) Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood, 99 (4). pp. 1136-1143. ISSN 0006-4971